Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs7790858 | chr7:127776159 | G/C | 1.78E-9 | 134 | 42.27 | 37.53 | 12.55 | KM Plot |
| TGCT | rs77958262 | chr6:15238009 | G/A | 6.08E-5 | 133 | 37.95 | 45.1 | NA | KM Plot |
| TGCT | rs7801895 | chr7:126927463 | G/C | 3.7E-6 | 132 | 42.1 | 65.47 | 57.52 | KM Plot |
| TGCT | rs7803526 | chr7:23686084 | G/A | 6.76E-5 | 129 | 30.45 | 36.23 | 49.93 | KM Plot |
| TGCT | rs78046790 | chr2:29497257 | A/G | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs7812812 | chr8:116902470 | C/T | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs7813113 | chr8:120873842 | C/T | 8.17E-5 | 134 | 45.7 | 37.3 | 17.1 | KM Plot |
| TGCT | rs78188950 | chr6:15236667 | C/T | 6.08E-5 | 133 | 37.95 | 45.1 | NA | KM Plot |
| TGCT | rs78261232 | chr2:29493798 | A/G | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs78313351 | chr7:127775902 | G/A | 1.78E-9 | 134 | 42.27 | 37.53 | 12.55 | KM Plot |
| TGCT | rs7832162 | chr8:116906330 | G/A | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs7832614 | chr8:103088573 | G/C | 0.000113 | 132 | 42.27 | 36.1 | 48.45 | KM Plot |
| TGCT | rs7836109 | chr8:116912796 | C/A | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs78410207 | chr1:42112627 | A/G | 0 | 132 | 42.03 | 28.8 | 0.57 | KM Plot |
| TGCT | rs78675401 | chr7:33054114 | CTT/C | 1.55E-5 | 133 | 42.1 | 39.78 | 75.65 | KM Plot |